Dr Stephen Wilson, CEO of the Botnar Institute of Immune Engineering, describes Basel's collaborative ecosystem and a 3-year roadmap linking research to global clinical partners.
Stephen Wilson
Advertisement
Stephen Wilson, PhD, is CEO of the Botnar Institute of Immune Engineering.
Articles by Stephen Wilson
BIIE CEO Dr Stephen Wilson outlines rapid growth plans and a multidisciplinary technology stack targeting global clinical translation.
BIIE CEO Dr Stephen Wilson explains why Basel's condensed innovation ecosystem was chosen for the institute’s translational research mission.
Advertisement
Latest Updated Articles
BIIE Aims to Be a Global Immune Engineering EmbassySeptember 24th 2026
Advertisement
Advertisement
Trending on BioPharm International
1
Zai Lab’s Long-Acting Atopic Dermatitis Bispecific Points to Every-12-Week Dosin
2
FDA Reportedly Pauses National Priority Voucher Pilot and Pauses CRL Publication
3
FDA Grants Kamau RMAT Designation to Nula-cel for Sickle Cell Disease
4
Ionis Reports 2-Year Donidalorsen (Dawnzera) Data in HAE Prophylaxis
5